Daily non-political popular news in brief.

New algorithm matches any tumor cells to best possible anti-cancer treatments

07-23-2007 · EurekAlert!

An algorithm that could help rapidly sort molecular information about a cancer patient's particular tumor and could help match this information to the right drug treatment would be a breakthrough of enormous value. Two University of Virginia researchers have pioneered just such a system. Using a panel of 60 diverse, human cancer cell lines from the National Cancer Institute (NCI-60), the researchers devised and tested an algorithm designed to match the best potential treatment(s) for a particular tumor in a particular patient.

Keywords: algorithm, matches, tumor, cells, possible, anti-cancer, treatments, matche, cell, anti, cancer, treatment

« Previous | Next »

Similar news on "New algorithm matches any tumor cells to best possible anti-cancer treatments":

Scientists take next step in understanding potential target for Ovarian cancer treatment
07-16-2007 · EurekAlert!
A traffic cop protein in the cell may have an even more important role: transporting a messenger protein that tells components in the nucleus to stop cell growth. Scientists are studying the normal function of a protein called 'km23', the traffic cop protein, because the team previously found altered forms of the protein in 42 percent of tumor tissue samples taken from women with Ovarian cancer. The discovery of this additional role may lead to diagnostic tools and earlier treatments for Ovarian cancer.
Similar news · Read more »
Fantastic Voyage: A New Nanoscale View Of The Biological World
10-06-2006 · ScienceDaily
Echoing the journey through the human body in "Fantastic Voyage," doctors might soon be able to track individual donor cells after a transplant, or to find where and how much of a cancer treatment drug there is within a cell. New technology described in a study published in the open access journal, Journal of Biology makes it possible to image and quantify molecules within individual mammalian or bacterial cells.
Similar news · Read more »
Oxidative stress stimulates p38 MAPK-mediated tumor suppression
02-12-2007 · EurekAlert!
A new study finds that p38-alpha MAPK can sense oxidative stress in cells and respond by inhibiting tumor formation. The research, published in the February issue of the journal Cancer Cell, published by Cell Press, provides exciting new insight into the specific mechanisms by which á suppresses the development of cancer and identifies possible targets for development of new anticancer therapeutics.
Similar news · Read more »
Tumor-reactive T cells boosted by hematopoietic stem cell transplantation
02-01-2007 · EurekAlert!
Treatment for skin cancer by infusion of tumor-reactive T cells requires patients to be pre-treated with agents that transiently decrease the number of immune cells (nonmyeloablative agents). A study in mice now indicates that pre-treatment with more intense immune cell-depleting strategies (known as myeloablative strategies) and a hematopoietic stem cell transplant enables infused tumor-reactive CD8+ T cells to increase in number more than pre-treatment with nonmyeloablative agents, and this correlates with increased tumor regression.
Similar news · Read more »
Antibody retards growth and induces death in liver cancer cells
07-11-2007 · EurekAlert!
Researchers from the University of Pittsburgh School of Medicine report a significant new advance in the search for an effective treatment for human liver cancer. Using a newly available monoclonal antibody, they demonstrated dramatic reductions in tumor cell proliferation and survival in human and mouse hepatocellular cancer cell lines. This finding has significant implications not only for the treatment of liver cancer but for a number of different types of cancer.
Similar news · Read more »
Therapeutic peptide frees the protein p73 to kill tumor cells
03-08-2007 · EurekAlert!
p53 suppresses tumor development by inducing tumor cell death. However, targeting p53 for the treatment of cancer is confounded by the fact that genetic mutations cause loss or inactivation of p53 in approximately 50 percent of human cancers. Now, a new study indicates that targeting the p53-related protein p73 in mice induces the regression of established tumors of human origin, leading to the suggestion that p73 might be a viable target for developing anticancer therapeutics.
Similar news · Read more »
2 heads are better than 1: 2 dysfunctional DNA repair pathways kill tumor cells
04-12-2007 · EurekAlert!
Individuals who inherit one mutant copy of any one of about 12 genes that make the proteins of the Fanconi Anemia pathway are at increased risk of developing cancer. This occurs when the remaining "good" copy of the gene becomes mutated in a specific cell type. However, hope of a new treatment for these cancers has now been provided by a new study indicating that inhibiting the protein ATM can kill these cancer cells.
Similar news · Read more »
Scientists follow familiar TRAIL to new cancer therapy
07-09-2007 · EurekAlert!
A new study identifies a combination therapy that may sensitize human cancer cells to a promising treatment currently being used in clinical trials. The research, published in the July issue of the journal Cancer Cell, published by Cell Press, provides a pharmacological method for enhancing the potency and effectiveness of a tumor necrosis factor death receptor ligand against a variety of human cancers.
Similar news · Read more »
Sensitivity to diverse range of chemotherapeutic drugs linked to common pathway
06-11-2007 · EurekAlert!
Using a functional genomic screen, scientists have defined elements that impact the responsiveness of cancer cells to drugs commonly used as anticancer therapeutics. The research, published in the June issue of the journal Cancer Cell, published by Cell Press, identifies individual genes that are associated with resistance to chemotherapeutic drugs, and sets the stage for future studies that may significantly enhance the ability to predict whether or not a particular tumor will respond to treatment.
Similar news · Read more »
A faster way to recover from chemotherapy and marrow transplant
06-20-2007 · EurekAlert!
Researchers at Children's Hospital Boston report finding a practical way to increase stem cells in blood, suggesting a possible treatment to help patients recover from chemotherapy or bone marrow transplant for cancer, regaining immune function more quickly. The discovery, reported in the June 21 Nature and made possible through high-volume drug screening in fish, marks the first time stem-cell production has been induced by a small-molecule drug.
Similar news · Read more »